Nettoomsättningen sjönk till 0,4 mkr (1,5 mkr) vilket var under vår förväntan om 1,5 mkr.
Q2: EBIT of SEK 7.2m (-43% vs. ABGSCe at 12.6m) ’21e EBIT -14% on Q2 numbers, -3% for ’22e-’23e Fair...
Redeye leaves a comment on Acarix following the release of its Q2 report.
Redeye provides its take on the Q2 report where we note an encouraging engagement among clinics, tho...
There are no big surprises in the Q2’21 financials of Asarina Pharma.
Redeye states that while sales came in lower than expectations, the company continues to impress on the cost side.
Redeye comments on Azelio’s largest order to date, corresponding to 20 TES.
The lead project Orviglance (also called Mangoral, an improved contrast agent addressing liver metas...
Redeye first comments on Dignitana's Q2 report. The sales development continues to be strong with a ...
Aspire reports solid Q2 numbers clearly beating our expectations as both B2B and B2C segments perfor...
Redeye states that while numbers were slightly below our expectations, we still argue that the repor...
Beijer Group posted a record order intake in Q2’21 of more than half a billion SEK.
Redeye was really surprised to see the weak Q2 numbers showing significantly lower revenues and negative earnings for the quarter.
Redeye highlights that Calliditas continue to progress with the lead candidate Nefecon and the compa...
We expect Sparekassen Kronjylland to continue to benefit from the current sector tailwinds – a stron...
Nettoomsättningen i Q2'21 uppgick till 480 mkr vs våra estimat om 418 mkr.
Redeye comments on OssDsign’s Q2 report and emphasizes that activities during and after the quarter ...
Redeye views the Q2 report, with record sales and a strong pipeline, as a strong sign of the company...
Due to some delays and changes the production guidance for 2021 was lowered to around 1,500 oz (prev.
Balco’s Q2 report showed a clear pick-up in order intake, although sales and earnings are still belo...
Cantargia reported its Q2 numbers this morning with an operating loss of SEK -86.
Idag offentliggjorde Ecoclime sin delårsrapport för andra kvartalet 2021.
Redeye's first comments on Scibase's Q2 report. The sales were slightly lower than expected; however...
Redeye is positive about Tuesday’s press release from aXichem, where it announced it has fully verified its production process.
DistIT Group has announced the acquisition of Efuel, a Swedish market leader (30% share) within the ...
Cibus’ strategy proceeds according to plan and further Nordic expansion seems inevitable.
